SANGAMO THERAPEUTICS, INC. AMENDED AND RESTATED AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENTSales Agreement • May 26th, 2017 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 26th, 2017 Company Industry JurisdictionSangamo Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: